Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA raises 2025 guidance as second-quarter diluted EPS rises 23.5% to $6.83

Positive Impact 4 of 5 guidance Written later

HCA Healthcare reported second-quarter 2025 revenue of $18.605 billion, up 6.4% from a year earlier, and net income attributable to the company of $1.653 billion, or $6.83 per diluted share, up 23.5%. The company raised its 2025 guidance, with diluted EPS now expected at $25.50 to $27.00, up from $24.05 to $25.85. The Board also declared a $0.72 per share quarterly dividend payable September 30, 2025.

Key points

  • Revenue of $18.605 billion, up 6.4% from $17.492 billion; net income attributable to HCA of $1.653 billion versus $1.461 billion
  • Adjusted EBITDA of $3.849 billion, up 8.4%; operating cash flow of $4.210 billion versus $1.971 billion a year earlier
  • Revised 2025 guidance: revenue $74.00 billion to $76.00 billion; net income attributable to HCA $6.11 billion to $6.48 billion; Adjusted EBITDA $14.70 billion to $15.30 billion
  • Quarterly dividend of $0.72 per share, record date September 16, 2025, payment date September 30, 2025

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECJul 25, 2025, 7:46 AM ET
Accession number0000950170-25-098578

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 25, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.